Ex-Google Exec's Stroke Prevention Startup AliveCor Gets $30 Million Post author:Sam Post published:March 16, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Alzheon To Present Novel Molecular Mechanism Of Action And Long Term Clinical Efficacy Data For Lead Candidate ALZ-801 At June 21, 2017 Valeant to Shave an Additional $200M From Its Mountain of Debt January 25, 2018 <b>Palleon Pharma</b> Bursts Onto the Scene With $47.6 Million and a New R&D Approach October 3, 2017
Alzheon To Present Novel Molecular Mechanism Of Action And Long Term Clinical Efficacy Data For Lead Candidate ALZ-801 At June 21, 2017
<b>Palleon Pharma</b> Bursts Onto the Scene With $47.6 Million and a New R&D Approach October 3, 2017